Skip to Main Content
Contribute Try STAT+ Today

The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” and alter their use of the medicines, such as cutting back or skipping dosages altogether. And many report the financial burden is not only hurting their lifestyle, but impairing their ability to save for retirement or college for their children, a new survey found.

For instance, 14% reported they switched to a generic, despite being satisfied with their existing treatment; 12% stopped using their medication for a period of time; 9% skipped or delayed filling a prescription; and 8% took less of their medicine than prescribed, according to the survey by the National Multiple Sclerosis Society.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • It’s horrible enough having this disease let alone having to worry about whether or not my insurance will continue to cover Aubagio. MS one to one thankfully covers the ridiculous co-pay. I have had MS 25 years and grateful to be fully functioning and still in the workforce. That would not be possible today without my medication

  • I’ve been on rituxan for several years then at Kaiser they changed the protocol and now I haven’t had an infusion for over a year been on no meds at all and when my counts do go up I will be given a different infusion that is a “copy” of rituxan biosimular
    At an lower cost to kaiser and me I think.

  • I have had to reduce or stop taking Many of my M. S. Meds through the years. I was dx’d wit M.S. 32+ years ago. Now I am just taking meds for the symptons…:(

Comments are closed.